ArticleJournal of enzyme inhibition and medicinal chemistry2024

Discovery of novel 2,4-diarylaminopyrimidine hydrazone derivatives as potent anti-thyroid cancer agents capable of inhibiting FAK.

Hongting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.